Shefali Luthra

The risks of punishment have deterred physicians, hospitals and health systems from providing consistent care, even when needed.

Using flawed studies and scientific journal publications, abortion opponents are building a body of research meant to question the safety of the abortion pill mifepristone, a key target for the movement.

Senate Bill 2880, which supporters hoped could halt a key source of abortion, will likely not get a vote before the end of the session.

Clinics are rebuilding services, patients are returning and Republicans in the state are moving quickly to take protections away — again.

The risk is greatest among Black women in states with abortion bans, according to a new report.

Diana Greene Foster, who was behind the landmark Turnaway Study, wanted to study the health and economic impacts of the loss of abortion access.

None of the bills are likely to become law. But they illustrate a growing divide in the anti-abortion movement and could punish pregnant people.

The Trump administration’s cuts to Title X could disrupt medical services for close to a million people, predominantly low-income Americans. 

The ruling — one of the first to explicitly address abortion-related travel — is a significant victory for abortion providers and supporters.

The case concerns a South Carolina policy that would prevent people from using Medicaid — which predominantly insures people of color — at the nation’s largest family planning provider.